The Smallpox Vaccine We Stopped Giving and What Came Back

The Smallpox Vaccine We Stopped Giving and What Came Back

When smallpox eradication was declared in nineteen eighty, routine vaccination ceased, removing a cross-protective shield against related orthopoxviruses. This episode explores the immunological consequences of that decision, how waning population immunity enabled zoonotic poxviruses to spill into humans, and how vaccine technology was modernized for twenty-first-century outbreaks.

Listen in the Fylom app.

Show notes

Ending routine smallpox vaccination removed broad cross-protection against other dangerous animal poxviruses worldwide.

Over seventy percent of the global population now completely lacks orthopoxvirus immunity.

Democratic Republic of the Congo saw mpox cases surge twenty-fold as unvaccinated birth cohorts grew.

Feral vaccinia variants adapted to livestock, triggering recurrent outbreaks among dairy workers in Brazil and India.

Up to one in one hundred seventy-five primary recipients of vaccine ACAM two thousand develop heart inflammation.

Modern non-replicating vaccines like MVA-BN offer safer alternatives for people living with advanced HIV.

In this episode
  1. 01Intro1 min
  2. 02The Disappearing Shield of Nineteen Eighty3 min
  3. 03The Widening Demographic Immunity Gap3 min
  4. 04The Resurgence of the Cousins2 min
  5. 05Modernizing an Old Countermeasure3 min
  6. 06Outro1 min
Sources
Your turn

Fylom generates episodes like this on any topic you're curious about.

Fylom episodes are researched, written, and voiced by AI. Automated checks help catch inaccuracies, but episodes aren't reviewed by a human and AI can still get things wrong. Treat them as a starting point, not a source of record — more in our accuracy disclaimer.

The Smallpox Vaccine We Stopped Giving and What Came Back — Fylom